与多发性硬化症患者长期利妥昔单抗治疗相关的炎症性阴道炎。
Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis.
机构信息
Department of Neurology, Copenhagen University Hospital Danish Multiple Sclerosis Research Center, Glostrup, Denmark
Department of Neurology, Copenhagen University Hospital Danish Multiple Sclerosis Research Center, Glostrup, Denmark.
出版信息
BMJ Case Rep. 2022 Nov 22;15(11):e250425. doi: 10.1136/bcr-2022-250425.
Abstract
We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy.More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.
摘要
我们描述了一种潜在的副作用，即长期使用利妥昔单抗治疗多发性硬化症可能导致的炎症性阴道炎，而没有任何其他系统性疾病或潜在恶性肿瘤的存在。需要更多的研究来描述长期接受利妥昔单抗治疗的女性中炎症性阴道炎的发生率。
相似文献
1
Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis.与多发性硬化症患者长期利妥昔单抗治疗相关的炎症性阴道炎。
BMJ Case Rep. 2022 Nov 22;15(11):e250425. doi: 10.1136/bcr-2022-250425.
2
Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders.长期接受利妥昔单抗治疗自身免疫性疾病的女性的炎症性阴道炎。
BMC Womens Health. 2021 Aug 5;21(1):285. doi: 10.1186/s12905-021-01423-0.
3
Inflammatory vaginitis in four B-cell suppressed women with Multiple Sclerosis.四名多发性硬化症 B 细胞抑制女性的炎症性阴道炎。
Mult Scler Relat Disord. 2024 Feb;82:105387. doi: 10.1016/j.msard.2023.105387. Epub 2023 Dec 16.
4
Rituximab-induced serum sickness in multiple sclerosis patients.利妥昔单抗诱导的多发性硬化症患者的血清病。
Mult Scler Relat Disord. 2019 Nov;36:101402. doi: 10.1016/j.msard.2019.101402. Epub 2019 Sep 17.
5
A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review.利妥昔单抗治疗多发性硬化后溃疡性结肠炎的病例报告及文献复习。
Mult Scler Relat Disord. 2018 May;22:22-26. doi: 10.1016/j.msard.2018.02.030. Epub 2018 Mar 1.
6
Severe neutropenia after rituximab-treatment of multiple sclerosis.利妥昔单抗治疗多发性硬化后严重中性粒细胞减少症。
Mult Scler Relat Disord. 2018 Feb;20:3-5. doi: 10.1016/j.msard.2017.12.005. Epub 2017 Dec 12.
7
Efficacy and safety of rituximab in treating patients with multiple sclerosis (MS): A systematic review and meta-analysis.利妥昔单抗治疗多发性硬化症（MS）患者的疗效与安全性：一项系统评价和荟萃分析。
Autoimmun Rev. 2020 Aug;19(8):102585. doi: 10.1016/j.autrev.2020.102585. Epub 2020 Jun 10.
8
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial.利妥昔单抗与二甲基富马酸在瑞典复发缓解型多发性硬化或临床孤立综合征患者中的安全性和疗效：一项盲法、3 期、随机对照试验。
Lancet Neurol. 2022 Aug;21(8):693-703. doi: 10.1016/S1474-4422(22)00209-5.
9
Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland.芬兰西南部区域医院使用利妥昔单抗治疗多发性硬化症。
Mult Scler Relat Disord. 2020 May;40:101980. doi: 10.1016/j.msard.2020.101980. Epub 2020 Feb 4.
10
Serious safety events in rituximab-treated multiple sclerosis and related disorders.利妥昔单抗治疗多发性硬化症及相关疾病的严重安全事件。
Ann Clin Transl Neurol. 2020 Sep;7(9):1477-1487. doi: 10.1002/acn3.51136. Epub 2020 Aug 6.
引用本文的文献
1
Gynecological health: A missing link in comprehensive treatment monitoring for multiple sclerosis.妇科健康：多发性硬化综合治疗监测中缺失的一环。
Mult Scler. 2025 Aug;31(9):1023-1031. doi: 10.1177/13524585251346371. Epub 2025 Jun 18.
本文引用的文献
1
Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders.长期接受利妥昔单抗治疗自身免疫性疾病的女性的炎症性阴道炎。
BMC Womens Health. 2021 Aug 5;21(1):285. doi: 10.1186/s12905-021-01423-0.
2
Vulvovaginal pyoderma gangrenosum associated with rituximab use in 2 patients with rheumatoid arthritis.2例类风湿关节炎患者使用利妥昔单抗后发生的外阴阴道坏疽性脓皮病
JAAD Case Rep. 2021 Feb 23;10:75-77. doi: 10.1016/j.jdcr.2021.02.013. eCollection 2021 Apr.
3
Incidence, Clinical Features, and Outcomes of Late-Onset Neutropenia From Rituximab for Autoimmune Disease.利妥昔单抗治疗自身免疫性疾病所致迟发性中性粒细胞减少症的发生率、临床特征及转归。
Arthritis Rheumatol. 2021 Feb;73(2):347-354. doi: 10.1002/art.41501. Epub 2020 Dec 29.
4
Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis.抗 CD20 单克隆抗体治疗复发缓解型和进展型多发性硬化症。
CNS Drugs. 2020 Mar;34(3):269-280. doi: 10.1007/s40263-020-00704-w.
5
A case of rituximab-induced pyoderma gangrenosum.1例利妥昔单抗诱发的坏疽性脓皮病。
JAAD Case Rep. 2018 Oct 29;4(10):979-981. doi: 10.1016/j.jdcr.2018.09.003. eCollection 2018 Nov.
6
Vulvovaginal pyoderma gangrenosum in association with rituximab.与利妥昔单抗相关的外阴阴道坏疽性脓皮病。
JAAD Case Rep. 2018 Oct 4;4(9):907-909. doi: 10.1016/j.jdcr.2018.09.001. eCollection 2018 Oct.
7
Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin.静脉注射免疫球蛋白成功治疗危及生命的利妥昔单抗诱导的坏疽性脓皮病
Scand J Rheumatol. 2017 Sep;46(5):413-414. doi: 10.1080/03009742.2016.1241298. Epub 2016 Nov 29.
8
Rituximab causing deep ulcerative suppurative vaginitis/pyoderma gangrenosum.利妥昔单抗引发深部溃疡性化脓性阴道炎/坏疽性脓皮病。
Curr Infect Dis Rep. 2015 May;17(5):478. doi: 10.1007/s11908-015-0478-5.
9
Etiology and management of pyoderma gangrenosum: a comprehensive review.坏疽性脓皮病的病因和治疗：全面综述。
Am J Clin Dermatol. 2012 Jun 1;13(3):191-211. doi: 10.2165/11595240-000000000-00000.
10
Superficial granulomatous pyoderma of the vulva in a patient receiving maintenance rituximab (MabThera) for lymphoma.外阴浅表肉芽肿性脓性皮肤病患者正在接受利妥昔单抗（美罗华）维持治疗淋巴瘤。
J Low Genit Tract Dis. 2011 Apr;15(2):158-60. doi: 10.1097/LGT.0b013e3181eb30ff.
Zotero 插件